Does Rapid FDA Approval Produce Drug Safety Issues?

/ Mar 16, 2020

Bart Cobert gives his pharmacovigilance point of view on a recent paper on FDA approval timelines and drug safety issues.

Read More Update

/ Feb 11, 2020

Bart Cobert on the importance of publishing clinical trials data and implications on pharmacovigilance.

Read More

Pharmacovigilance 2030

/ Dec 11, 2019

This is an interesting article looking at what PV will be in the year 2030.

Read More

FDA Draft Guidance on PMRs

/ Nov 24, 2019

Bart Cobert highlights the most important changes in the recently revised FDA draft guidance on PMRs.

Read More

Ranitidine – What Happened and What Do We Learn?

/ Oct 31, 2019

Bart Cobert explores several important points to take from the still ongoing signal and safety issue with Renitidine recall.

Read More

Video Email: Your Secret Weapon in Improving cSat

/ Oct 23, 2019

The advantages of utilizing video email response to overcome low customer satisfaction.

Read More

Why Coupons Are Still a Powerful Strategy for Brands

/ Oct 14, 2019

When it comes to driving consumer behavior, coupons continue to be a powerful force.

Read More

Going Mobile: Creating Experiences that Matter with the Avaya Mobile Experience

/ Oct 14, 2019

Read how C3i Solutions is leveraging Avaya Mobile Experience to provide better customer experience.

Read More

Vaping – A Serious Safety Signal

/ Oct 07, 2019

Bart Cobert discusses the major safety issue in the US on e-cigarettes and vaping.

Read More

Importing Canadian Drugs to the US

/ Aug 29, 2019

Bart Cobert covers several issues involved in setting up the proposed "Safe Importation Plan" which aims to allow US consumers to get safe and cheaper drugs.

Read More

Blog Signup